Skip to Main Content

Author Details

Kenneth W Kinzler
1986
460
206
PMIDPaper TitleJournal TitlePublished Year
36596784The rapid and highly parallel identification of antibodies with defined biological activities by SLISY.Nat Commun2023
37948357Radiologists' Expectations of Artificial Intelligence in Pancreatic Cancer Imaging: How Good Is Good Enough?2023
37604828Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.2023
37565753The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer.Cancer Discov2023
37626188Author Correction: 14-3-3Ï¿ is required to prevent mitotic catastrophe after DNA damage.Nature2023
37552989Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.Cell Rep Med2023
37014860Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules.Proc Natl Acad Sci U S A2023
35178604Correction to: Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.Virchows Archiv2022
35657320Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.New England Journal of Medicine2022
35394875TCR-mimic bispecific antibodies to target the HIV-1 reservoir.Proc Natl Acad Sci U S A2022
36098760Classification of pancreatic cystic neoplasms using radiomic feature analysis is equivalent to an experienced academic radiologist: a step toward computer-augmented diagnostics for radiologists.Abdominal Radiology2022
35692635An isogenic cell line panel for sequence-based screening of targeted anticancer drugs.iScience2022
35122030Author Correction: Targeting public neoantigens for cancer immunotherapy.Nature Cancer2021
33493502Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus.Gastroenterology2021
33491650Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer.Elife2021
34290408Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.Nature2021
34114951Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.Elife2021
33731480Targeting loss of heterozygosity for cancer-specific immunotherapy.Proceedings of the National Academy of Sciences of the United States of America2021
33941929Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands.Nature Biotechnology2021
33939694Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.PLoS Medicine2021
33869251The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19.Front Med (Lausanne)2021
33649188TCR β chain-directed bispecific antibodies for the treatment of T cell cancers.Sci Transl Med2021
33649166Targeting a neoantigen derived from a common mutation.Science2021
33649101Bispecific antibodies targeting mutant neoantigens.Science immunology2021
32984952Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.International Journal of Cancer2021
33398294The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19.medRxiv2021
34676374Targeting public neoantigens for cancer immunotherapy.Nature Cancer2021
34608287Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.Nature2021
34380662Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers.Journal for ImmunoTherapy of Cancer2021
34489470Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.Nature Communications2021
31358460Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation.Diagnostic and interventional imaging2020
32075918Assessing aneuploidy with repetitive element sequencing.Proc Natl Acad Sci U S A2020
31629672Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis.Diagnostic and interventional imaging2020
32352407Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists.J Clin Invest2020
31882448Revisiting the tumorigenesis timeline with a data-driven generative model.Proc Natl Acad Sci U S A2020
32345712Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.Science2020
32446597Erratum to "Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation" [Diagn. Interv. Imaging. 101 (2020) 35-44].Diagnostic and interventional imaging2020
33033144Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia.Cancer Epidemiology Biomarkers and Prevention2020
31482302Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.Virchows Archiv2020
31462507Applications of liquid biopsies for cancer.Sci Transl Med2019
31690625An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation.Journal of Biological Chemistry2019
31621801Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.JAMA Oncology2019
30560554Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.Journal of Pathology2019
30447301Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.Human Pathology2019
30628066The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations.International Journal of Cancer2019
29420226Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.Gut2019
31527070Direct Detection and Quantification of Neoantigens.Cancer Immunology Research2019
31492412Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience.Journal of the American College of Radiology2019
31028363Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.Modern Pathology2019
31455892An analysis of genetic heterogeneity in untreated cancers.Nature Reviews Cancer2019
  • 1 - 50 of 460

Recommended Authors

Collaborators

Co-authored papers 437
Co-authored papers 150
Co-authored papers 85
Co-authored papers 53
Co-authored papers 42
Co-authored papers 27
Dana Farber Cancer Institute.
Co-authored papers 25
Johns Hopkins University
Co-authored papers 21
Co-authored papers 21
Co-authored papers 20
The University of Texas MD Anderson Cancer Center
Co-authored papers 19
Texas Children's Hospital
Co-authored papers 17
Co-authored papers 16
Co-authored papers 15
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 14
Co-authored papers 13
Co-authored papers 11
Mayo Clinic
Co-authored papers 11
University of South Carolina
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Co-authored papers 9
University of Colorado School of Medicine
Co-authored papers 9
Cleveland Clinic.
Co-authored papers 9
Co-authored papers 9
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Co-authored papers 9
Vanderbilt University Medical Center
Co-authored papers 8
Howard Hughes Medical Institute
Co-authored papers 8
The Ohio State University Comprehensive Cancer Center
Co-authored papers 8
Co-authored papers 8